Quest Diagnostics Incorporated
DGX NYSEHealthcare ★★★★★Latest Earnings
Date
Jul 23, 2026
ET
EPS Est.
2.82
EPS Actual
3.12
Revenue Est.
$2.97B
Revenue Actual
$3.04B
Next Earnings Report Date unconfirmed
Date
Oct 20, 2026 · Tue
Time
Time TBD
Fiscal Period
--
EPS Est.
2.85
Revenue Est.
$3.04B
Company Overview
Quest Diagnostics Incorporated (ticker DGX) is listed on NYSE with a market cap of about $26.97B. Its next earnings report is expected on Oct 20, 2026 (ET), Time TBD (date pending company confirmation), with consensus EPS of 2.85. In the last 15 reported quarters, EPS beat consensus estimates 15 times.
Actual EPS TrendRecently15Term · Feb 2, 2023 → Jul 23, 2026
Feb 2, 2023Range: 1.98 ~ 3.12Jul 23, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 23, 2026 | -- | 2.82 | 3.12 | $2.97B | $3.04B |
| Apr 21, 2026 | -- | 2.37 | 2.50 | $2.83B | $2.9B |
| Feb 10, 2026 | -- | 2.36 | 2.42 | $2.75B | $2.81B |
| Oct 21, 2025 | -- | 2.50 | 2.60 | $2.74B | $2.82B |
| Jul 22, 2025 | -- | 2.57 | 2.62 | $2.73B | $2.76B |
| Apr 22, 2025 | -- | 2.15 | 2.21 | $2.63B | $2.65B |
| Jan 30, 2025 | -- | 2.19 | 2.23 | $2.58B | $2.62B |
| Oct 22, 2024 | -- | 2.26 | 2.30 | $2.43B | $2.49B |
| Jul 23, 2024 | -- | 2.34 | 2.35 | $2.39B | $2.4B |
| Apr 23, 2024 | -- | 1.86 | 2.04 | $2.29B | $2.37B |
| Feb 1, 2024 | -- | 2.11 | 2.15 | $2.25B | $2.29B |
| Oct 24, 2023 | -- | 2.19 | 2.22 | $2.27B | $2.3B |
| Jul 26, 2023 | -- | 2.27 | 2.30 | $2.25B | $2.34B |
| Apr 27, 2023 | -- | 1.97 | 2.04 | $2.2B | $2.33B |
| Feb 2, 2023 | -- | 1.90 | 1.98 | $2.26B | $2.33B |
Original Filings (SEC)
Quarterly10-Q · 2026-07-23 ↗
Earnings Release8-K · 2026-07-23 ↗
Quarterly10-Q · 2026-04-22 ↗
Earnings Release8-K · 2026-04-21 ↗
Annual10-K · 2026-02-26 ↗
Earnings Release8-K · 2026-02-10 ↗
Earnings Release8-K · 2025-10-21 ↗
Quarterly10-Q · 2025-10-21 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
